Please provide your email address to receive an email when new articles are posted on . Pneumonia, hoarse voice and oral thrush were the greatest burdens with inhaled corticosteroids. Patients also ...

Background and Goal: Inhaled corticosteroids (ICS) are commonly prescribed for chronic obstructive pulmonary disease (COPD), but not recommended as first-line treatment unless patients have ...

Most people with asthma are able to control their symptoms by using inhaled medicines each day. But for some people with severe asthma, inhaled medicines are not enough to keep symptoms under control.

Please provide your email address to receive an email when new articles are posted on . Nearly 45% of veterans with COPD received inhaled corticosteroids as their first therapy without meeting a ...

Prepubertal children treated with inhaled glucocorticoids for asthma show an initial reduced growth velocity. [1] When these observations were first made, it was not known whether the initial drop in ...

Benefit of inhaled corticosteroids for sinusitis small Review shows benefits of inhaled corticosteroids may be greater at higher doses and longer duration, but lower cost over-the-counter remedies may ...

The use of inhaled corticosteroids (ICS) during pregnancy may diminish the association between maternal asthma and reduced infant lung function and thus may improve respiratory health in infants born ...

Inhaled corticosteroids (ICSs) are a key incorporation to COPD treatment strategies. Jeffrey D. Dunn, PharmD, MBA: ICSs [inhaled corticosteroids] haven’t shown much evidence in impacting the course of ...

Most people with asthma are able to control their symptoms by using inhaled medicines each day. But for some people with severe asthma, inhaled medicines are not enough to keep symptoms under control.

Patterns of mortality in lung cancer patients in the era of immunotherapy and targeted therapy: A single-center, retrospective, observational study. This is an ASCO Meeting Abstract from the 2025 ASCO ...

Asthma is an umbrella diagnosis covering a number of heterogeneous inflammatory pathways. In the past, excessive T-helper cell type 2 (Th2) response and immunoglobulin E (IgE) sensitivity were thought ...